- Home
- CLDI vs FEDU Comparison
CLDI vs FEDU Comparison
Compare CLDI & FEDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- FEDU
- Stock Information
- Founded
- CLDI 2014
- FEDU 2007
- Country
- CLDI United States
- FEDU China
- Employees
- CLDI N/A
- FEDU N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- FEDU
- Sector
- CLDI Health Care
- FEDU
- Exchange
- CLDI Nasdaq
- FEDU NYSE
- Market Cap
- CLDI 14.0M
- FEDU 20.0M
- IPO Year
- CLDI N/A
- FEDU 2017
- Fundamental
- Price
- CLDI $0.48
- FEDU $7.72
- Analyst Decision
- CLDI Strong Buy
- FEDU
- Analyst Count
- CLDI 2
- FEDU 0
- Target Price
- CLDI $15.00
- FEDU N/A
- AVG Volume (30 Days)
- CLDI 387.2K
- FEDU 16.5K
- Earning Date
- CLDI 05-13-2025
- FEDU 12-20-2024
- Dividend Yield
- CLDI N/A
- FEDU 29.53%
- EPS Growth
- CLDI N/A
- FEDU N/A
- EPS
- CLDI N/A
- FEDU 0.12
- Revenue
- CLDI N/A
- FEDU $27,971,139.00
- Revenue This Year
- CLDI N/A
- FEDU N/A
- Revenue Next Year
- CLDI N/A
- FEDU N/A
- P/E Ratio
- CLDI N/A
- FEDU $64.77
- Revenue Growth
- CLDI N/A
- FEDU 141.14
- 52 Week Low
- CLDI $0.35
- FEDU $3.69
- 52 Week High
- CLDI $4.90
- FEDU $22.70
- Technical
- Relative Strength Index (RSI)
- CLDI 39.49
- FEDU 47.63
- Support Level
- CLDI $0.41
- FEDU $6.73
- Resistance Level
- CLDI $0.52
- FEDU $7.89
- Average True Range (ATR)
- CLDI 0.07
- FEDU 0.95
- MACD
- CLDI 0.02
- FEDU 0.15
- Stochastic Oscillator
- CLDI 66.50
- FEDU 78.19
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About FEDU FOUR SEASONS EDUCATION (CAYMAN) INC SPON ADS EACH REP 10 ORD SHS(R/S)
Four Seasons Education (Cayman) Inc is engaged in the provision of after-school education services for kindergarten, elementary and middle school students. The Company derives its revenue from learning services, tourism services, and learning technology and content solutions. The company is a comprehensive educational enterprise that provides research practice services, educational informatization equipment, high-quality educational resources, and teacher training, as well as a digital publishing business, and continues to expand in educational research and educational informatization.